The link between pre-existing AF and ARDS incidence in the clinical contest of COVID-19 might be related to the increased ACE2 expression in AF patients [22], which may promote the cell binding of SARS-CoV-2 and the inflammatory host response [23]. The gene discussed is ACE2; the disease is COVID-19.